TickerFactsScreenerDevelopers

Amphastar Pharmaceuticals, Inc. (AMPH) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2012: $114.02M2013: $142.72M2014: $159.21M2015: $174.17M2016: $150.97M2017: $149.67M2018: $187.68M2019: $190.43M2020: $206.51M2021: $238.03M2022: $250.13M2023: $293.27M2024: $358.11M2025: $363.83M$363.83M
2012Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$363.83M+1.6%
2024$358.11M+22.1%
2023$293.27M+17.3%
2022$250.13M+5.1%
2021$238.03M+15.3%
2020$206.51M+8.4%
2019$190.43M+1.5%
2018$187.68M+25.4%
2017$149.67M-0.9%
2016$150.97M-13.3%
2015$174.17M+9.4%
2014$159.21M+11.5%
2013$142.72M+25.2%
2012$114.02M—